LONDON -- It was best that people interrupt their oral anticoagulation (OAC) therapy around the time they get transcatheter aortic valve replacement (TAVR, also TAVI), the POPular PAUSE TAVI trial ...
CMS accepted a request from Edwards Lifesciences for a new coverage determination (NCD) for transcatheter aortic valve ...
SAN ANTONIO, TX—More and more patients who undergo TAVI go on to have cardiac surgery, with high operative mortality, new data from the Society of Thoracic Surgeons (STS) Adult Cardiac Surgery ...
The heart team at University Hospitals, Cleveland, OH, was in the midst of implanting a transcatheter aortic valve in an elderly patient when things went abruptly wrong. “The pacemaker happened to ...
Edwards pushes CMS to expand Medicare TAVR coverage as agency opens public comment period through January 2026 for decision.
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window With protamine ...
PARIS — Despite some potential advantages, transcatheter aortic valve implantation (TAVI) failed to meet the primary prespecified threshold for noninferiority to surgical aortic valve replacement in ...
PLYMOUTH MEETING, Pa. (WPVI) -- The TAVR procedure has revolutionized a challenging task in heart care: fixing stiff valves. And it has made the process much easier for patients, getting them back to ...
Greater access to transcatheter aortic valve replacement (TAVR) may be associated with improved outcomes in patients with severe aortic stenosis, data suggest. In an observational, retrospective ...
COLLEGEVILLE, Pa.--(BUSINESS WIRE)--Thubrikar Aortic Valve, Inc. today announced successful results in an additional 5 patients implanted with the Optimum Transcatheter Aortic Valve (Optimum TAV™) ...
Please provide your email address to receive an email when new articles are posted on . Temporarily stopping anticoagulant use during TAVR was safe among patients undergoing the procedure. An ...
A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...